about
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials.Treatment options for sexual dysfunction in patients with chronic kidney disease: a systematic review of randomized controlled trialsClustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinomaMeta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease.Geographical variations in sex ratio trends over time in multiple sclerosis.High Total Cholesterol in Peripheral Blood Correlates with Poorer Hearing Recovery in Idiopathic Sudden Sensorineural Hearing LossThe Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis.Advances in meta-analysis: examples from internal medicine to neurology.The burden of hospitalization related to diabetes mellitus: a population-based study.Joint spatial analysis of gastrointestinal infectious diseases.Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis.Nuclear receptors expression chart in peripheral blood mononuclear cells identifies patients with Metabolic Syndrome.MR in the evaluation of new anterior cruciate ligament and tibial tunnel position: correlation with clinical and functional features.Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir.
P50
Q33515541-CC3C4040-6210-4242-A367-FEFD63B4BF0EQ33836604-FFE20162-4657-4961-B61B-14F658A8BA31Q33888333-168F9290-95E2-4A96-8172-DF9A6EBB290BQ34035095-4F0B2822-81DE-4A36-AD53-57C4ED223792Q34113506-19110CAF-0550-4417-817E-C301156C4838Q34469310-AA03927B-FB68-42AB-9926-5B8E3FCEE577Q35712135-CFC08BF8-21DB-42E8-AFE5-79A3CE2F04F3Q36062456-9F7398C0-AD25-42A9-B174-6B0E0CAF0A47Q38047663-13B9F6D3-C002-42EA-BA5A-594A02FB2936Q38172773-74AC0F63-8F2E-403C-B99B-75CD29416164Q39781375-FE023C99-39F2-428E-8C31-5A37224F0D0EQ41451478-EEC998F9-2A91-4723-B29E-3DF05086CE08Q42468728-26B02345-4A33-4930-A970-457F4E2FC54DQ50720066-04452291-2516-4399-984E-C22B70D3559DQ51576809-EB6180B3-0CA9-4544-ACD2-2BD7AC0E91D0Q53201542-EA28010C-40DF-4BBE-AA0A-6781B8CF32BF
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Giusi Graziano
@ast
Giusi Graziano
@en
Giusi Graziano
@es
Giusi Graziano
@nl
type
label
Giusi Graziano
@ast
Giusi Graziano
@en
Giusi Graziano
@es
Giusi Graziano
@nl
prefLabel
Giusi Graziano
@ast
Giusi Graziano
@en
Giusi Graziano
@es
Giusi Graziano
@nl
P108
P106
P1153
35198052800
P31
P496
0000-0002-3347-8049